Target intelligence / Profile preview

CDK2-associated and cullin domain-containing protein 1 (CACUL1)

Target
CACUL1
Molecular classification
Other (Cullin domain–containing protein), Enzyme-associated scaffold/adaptor
01

Overview

CDK2-associated and cullin domain-containing protein 1 (CACUL1) is a multifunctional cullin domain protein that regulates cell cycle progression, apoptosis, transcription, and stress responses[1][2][3][4]. CACUL1 promotes cell proliferation by enhancing CDK2 activity at the G1/S transition and is frequently overexpressed in a variety of malignancies, correlating with tumor growth, chemoresistance, and metastasis[1][2][3]. It also functions as a transcriptional modulator—repressing activity of PPARγ and androgen receptor, inhibiting SUMOylation of PML, and modulating Nrf2 ubiquitination through association with the Cul3-Keap1 complex, thereby impacting antioxidant stress response and sensitizing cells to oxidative stress[1][2]. Its expression is subject to regulation by microRNAs in cancer and it is implicated as a potential therapeutic target in cancers and metabolic disorders[1][2][3][4].

Other names
CDK2 associated cullin domain 1CACUL1CDK2-associated and cullin domain-containing protein 1CAC1C10orf46FLJ40409MGC33215Cdk-associated cullin 1cullin
02

Biological functions

Cell cycle progression (G1/S transition)Positive regulation of cell proliferationRegulation of apoptosisTranscriptional modulationOxidative stress response
03

Disease associations

Cancer (including gastric, colorectal, lung, glioma, esophageal carcinoma, retroperitoneum carcinoma)Metabolic disorderPossible role in neurodegenerative disease (Alzheimer disease, suggested)
04

Safety considerations

Potential risk if broadly targeting CACUL1 due to roles in cell cycle, stress response, and multiple normal tissuesOncogenic potential if upregulated
05

Biomarkers

CACUL1 overexpression (biomarker of tumor growth, chemoresistance, cancer progression)

Beyond the preview

Go deeper on CDK2-associated and cullin domain-containing protein 1 (CACUL1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CDK2-associated and cullin domain-containing protein 1 (CACUL1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call